Atara Biotherapeutics's total assets for Q2 2025 were $36.90M, a decrease of -40.52% from the previous quarter. ATRA total liabilities were $71.94M for the fiscal quarter, a -38.57% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.